Todd Chappell
About Todd Chappell
Todd Chappell is the Chief Operating Officer with extensive experience in pharmaceutical and medical device industries, having led multiple early-stage therapeutic programs and served as CEO for two companies.
Todd Chappell Chief Operating Officer
Todd Chappell is the Chief Operating Officer, a role that leverages his extensive experience in managing and directing business operations in the pharmaceutical and medical sectors. Within this position, he brings strategic leadership and operational oversight to the company, ensuring alignment with business goals and objectives.
Todd Chappell Education and Expertise
Todd Chappell holds a B.S. from the University of California at Los Angeles and an MBA from Boston University. His academic background in both science and business provides him with the expertise required to navigate the complexities of the biotech and pharmaceutical industries, particularly in areas related to strategic planning and business management.
Todd Chappell Background
Todd Chappell has a robust background in the biotech and pharmaceutical industries. He previously served as the senior vice president of strategy and portfolio planning at Korro Bio. His career also includes the roles of CEO for Rasio Therapeutics, Inc. and Perceptive Navigation, LLC. He has experience managing a portfolio of start-up pharmaceutical and medical device companies as an entrepreneur-in-residence partnered with Johns Hopkins University, NIH, MedImmune, NEA, and SROne.
Todd Chappell Achievements
Throughout his career, Todd Chappell has led several early-stage therapeutic programs from discovery through to clinical trials. At Shape Pharmaceuticals, Inc., he managed the development of a novel HDAC inhibitor for Cutaneous-T-Cell-Lymphoma. During his tenure at CombinatoRx, Inc., he successfully advanced three programs from assay stage into human clinical studies, underscoring his proficiency in therapeutic program development and operational leadership.